SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report: July 21, 2004
Date of earliest event reported: July 21, 2004
PFIZER INC.
(Exact name of registrant as specified in its charter)
Delaware 1-3619 13-5315170
(State or other (Commission File (I.R.S. Employer
jurisdiction of (Number) Identification No.)
incorporation)
235 East 42nd Street 10017
New York, New York (Zip Code)
(Address of principal executive offices)
Registrant's telephone number, including area code:
(212) 573-2323
Item 7(c). Exhibits
Exhibit 99 - Press Release of Pfizer Inc. dated
July 21, 2004, reporting Pfizer's financial
results for the second quarter of 2004.
Item 12. Results of Operations and Financial Condition
On July 21, 2004, Pfizer Inc. issued a press release announcing its financial
results for the second quarter of 2004. A copy of the press release is furnished
as Exhibit 99 to this report and is incorporated herein by reference.
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant
has caused this report to be signed on its behalf by the authorized undersigned.
PFIZER INC.
By: /s/ Margaret M. Foran
-------------------------------
Margaret M. Foran
Title: Vice President-Corporate
Governance and Secretary
Dated: July 21, 2004
EXHIBIT INDEX
Exhibit No. Description
99 Press Release of Pfizer Inc. dated July 21, 2004,
reporting Pfizer's financial results for the second
quarter of 2004.